The CRISPR-cas system has revolutionized biological science. This genome editing tool has a powerful therapeutic potential, ranging from rare inherited diseases, to Alzheimer’s, cancer or bacterial infections. The biggest advantage of CRISPR technology is its simplicity to implement changes in DNA that remain stable, resulting in a truly edited genome. However, the implications of CRISPR are well beyond experimental science: are we ready to rewrite the human genome?
RSVP/submit questions for the panelists here: https://email@example.com
- Marc Güell, Wyss Technology Development Fellow, Wyss Institute for Biological Inspired Engineering, Harvard University
- Rosario Fernández-Godino, Senior Postdoctoral Researcher, MEEI-Harvard Medical School
- César de la Fuente, Postdoctoral Associate, Massachusetts Institute of Technology, Broad Institute of MIT and Harvard
- Rachel E. Sachs, Academic Fellow, Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics, Harvard Law School
Date an place:
March 24, Thursday, 6:15 pm. Instituto Cervantes at Harvard University (FAS)
2 Arrow Street 4th fl. #430, Cambridge, MA 02138 - USA
RSVP here: https://ecusabostonmarch2016.eventbrite.com
This event is part of the ECUSA Science Nights series.